These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7764474)

  • 1. Targeted delivery of toxins and enzymes by antibodies and growth factors.
    Houston LL
    Curr Opin Biotechnol; 1993 Dec; 4(6):739-44. PubMed ID: 7764474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxin therapy of lymphoma.
    Grossbard ML; Nadler LM
    Cancer Treat Res; 1993; 68():111-31. PubMed ID: 8105846
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotoxins in cancer therapy: Review and update.
    Akbari B; Farajnia S; Ahdi Khosroshahi S; Safari F; Yousefi M; Dariushnejad H; Rahbarnia L
    Int Rev Immunol; 2017 Jul; 36(4):207-219. PubMed ID: 28282218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic use of immunotoxins.
    Cobb PW; LeMaistre CF
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):6-13. PubMed ID: 1509295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxin therapy of lymphoid neoplasms.
    Grossbard ML; Nadler LM
    Semin Hematol; 1994 Jan; 31(1):88-97. PubMed ID: 8122137
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationale for the clinical use of immunotoxins: monoclonal antibodies conjugated to ribosome-inactivating proteins.
    Preijers FW
    Leuk Lymphoma; 1993 Mar; 9(4-5):293-304. PubMed ID: 8348066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology].
    Chiron MF
    Bull Cancer; 1997 Dec; 84(12):1135-40. PubMed ID: 9587366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotoxins: is there a clinical value?
    Gottstein C; Winkler U; Bohlen H; Diehl V; Engert A
    Ann Oncol; 1994; 5 Suppl 1():97-103. PubMed ID: 7826425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of immunotoxins in leukemia and lymphoma.
    Winkler U; Barth S; Schnell R; Diehl V; Engert A
    Ann Oncol; 1997; 8 Suppl 1():139-46. PubMed ID: 9187448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-cytotoxic agent conjugates for cancer therapy.
    Chen J; Jaracz S; Zhao X; Chen S; Ojima I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):873-90. PubMed ID: 16296784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotoxins in the therapy of cancer: from bench to clinic.
    Ghetie V; Vitetta E
    Pharmacol Ther; 1994 Sep; 63(3):209-34. PubMed ID: 7831391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation treatment of B cell malignancies with immunoconjugate.
    DeNardo GL; DeNardo SJ; O'Grady LF; Mills SL; Lewis JP; Macey DJ
    Front Radiat Ther Oncol; 1990; 24():194-201; discussion 202-3. PubMed ID: 2341050
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted kill: from umbrellas to monoclonal antibodies.
    Byers VS; Baldwin RW
    J Clin Immunol; 1992 Nov; 12(6):391-405. PubMed ID: 1287032
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant toxins for the treatment of cancer.
    Kreitman RJ
    Curr Opin Mol Ther; 2003 Feb; 5(1):44-51. PubMed ID: 12669470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotoxins: a clinical review of their use in the treatment of malignancies.
    Hertler AA; Frankel AE
    J Clin Oncol; 1989 Dec; 7(12):1932-42. PubMed ID: 2685183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
    Fishwild DM; Aberle S; Bernhard SL; Kung AH
    Cancer Res; 1992 Jun; 52(11):3056-62. PubMed ID: 1375534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials with blocked ricin immunotoxins.
    O'Toole JE; Esseltine D; Lynch TJ; Lambert JM; Grossbard ML
    Curr Top Microbiol Immunol; 1998; 234():35-56. PubMed ID: 9670611
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotoxins: an update.
    Thrush GR; Lark LR; Clinchy BC; Vitetta ES
    Annu Rev Immunol; 1996; 14():49-71. PubMed ID: 8717507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.